Open Targets
- | |
BioGen, Wellcome Sanger Institute | |
United Kingdom, United States | |
Open Targets designed and developed an integration and visualization platform that provides evidence about the association of known and potential drug targets with diseases. The platform is designed to support identification and prioritization of biological targets for follow-up. Each drug target is linked to a disease using integrated genome-wide data from a broad range of data sources. The platform provides either a target-centric workflow to identify diseases that may be associated with a specific target, or a disease-centric workflow to identify targets that may be associated with a specific disease. Users can easily transition between these target- and disease-centric workflows. | |
Genome/Gene, Health/Disease, Drug | |
Bibliography/Documents, Phenotype, Interaction/Pathway, Method | |
PubMed ID: DOI: | |
English | |
Active | |
- | |
- | |
- | |
- | |
- | |
- |
See the corresponding part in the FAIRsharing record. | |
(2018-12-21) | |
2019-03-28 | |
2024-07-28 | |
Creative Commons Attribution and Share-alike (CC-BY-SA) International 4.0 license |